Laryngeal disorder
MONDO:0004382A non-neoplastic or neoplastic disorder that affects the larynx. Representative examples include laryngitis, vocal cord polyp, squamous papilloma, and carcinoma.
Also known as: disease of larynx, disease or disorder of larynx, disorder of larynx, disorder of the larynx, laryngeal disease, laryngeal disorder, larynx disease, larynx disease or disorder
259 clinical trials for this condition and its sub-types, 44 tagged with Laryngeal disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Laryngeal disorder
-
Laryngeal neoplasm 72 trials · 138 incl. sub-types
6 sub-types
- Larynx cancer 41 trials · 125 incl. sub-types Sub-types →
- Glottis neoplasm 3 trials · 12 incl. sub-types Sub-types →
- Supraglottis neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Benign laryngeal neoplasm 1 trial · 2 incl. sub-types Sub-types →
- Subglottis neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Laryngeal neuroendocrine neoplasm 0 trials Sub-types →
-
Spasmodic dystonia 39 trials
-
Voice disorders 18 trials
-
Laryngeal abductor paralysis 10 trials
-
Congenital laryngeal palsy 9 trials
-
Laryngitis 2 trials · 8 incl. sub-types
4 sub-types
- Acute laryngitis 1 trial · 6 incl. sub-types Sub-types →
- Laryngotracheitis 1 trial · 5 incl. sub-types Sub-types →
- Chronic laryngitis 0 trials
- Laryngeal tuberculosis 0 trials
-
Congenital subglottic stenosis 7 trials
-
Idiopathic subglottic stenosis 7 trials
-
Polyp of vocal cord 7 trials
-
Laryngostenosis 3 trials
-
Congenital laryngomalacia 1 trial
-
H syndrome 0 trials
-
Acquired laryngomalacia 0 trials
-
Congenital laryngeal cyst 0 trials
-
Congenital laryngeal web 0 trials
-
Laryngeal diphtheria 0 trials
-
Laryngeal granuloma 0 trials
-
Laryngocele 0 trials
-
Larynx atresia 0 trials
-
Primary laryngeal lymphangioma 0 trials
Most studied deeper sub-types
-
Can a new drug combo slow advanced head and neck cancer?
Disease control Recruiting nowThis phase 2 trial tests an experimental drug called ficerafusp alfa, which targets two proteins that help tumors grow, when given with the immunotherapy pembrolizumab. The study enrolls adults with recurrent or metastatic head and neck squamous cell carcinoma that has not been t…
Phase 2 • Sponsor: Bicara Therapeutics • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New combo therapy aims to shrink head and neck tumors that resist standard treatment
Disease control Recruiting nowThis study tests whether adding an experimental drug called ficerafusp alfa to the immunotherapy pembrolizumab (Keytruda) works better than pembrolizumab alone for people with PD-L1-positive head and neck cancer that has spread or returned. About 650 adults will be randomly assig…
Phase 2/3 • Sponsor: Bicara Therapeutics • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New combo therapy aims to boost survival in head and neck cancer
Disease control Recruiting nowThis study tests whether adding petosemtamab to the standard immunotherapy pembrolizumab helps people with advanced head and neck cancer live longer. About 700 adults with PD-L1 positive cancer that has spread or come back will receive either the combination or pembrolizumab alon…
Phase 3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a shorter chemo schedule work as well for head and neck cancer?
Disease control Recruiting nowThis study compares two ways of giving the chemotherapy drug 5-FU to people with head and neck cancer that has spread or come back after prior treatments. One group gets the drug over two days every two weeks, the other over four days every three weeks. The goal is to see which s…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Biomarker-Guided trial aims to find best chemo for head and neck cancer
Disease control Recruiting nowThis study tests which chemotherapy combination works better when given with radiation for advanced head and neck cancer. About 120 adults with stage III or IV disease will receive either cisplatin or a mix of docetaxel and cetuximab. Researchers will also check if a tumor marker…
Phase 2 • Sponsor: Christopher Wilke • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New MRI-Guided radiation trial aims to sharpen cancer treatment
Disease control Recruiting nowThis study tests whether a new type of radiation machine that uses MRI to guide treatment is safe and practical for people with gastric, breast, or other cancers. About 70 adults will receive radiation guided by real-time MRI, sometimes with chemotherapy. The goal is to see if th…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called VMD-928, taken as a pill, either alone or with another cancer drug (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have not responded to or are no longer controlled by available treatments. The goal is to …
Phase 1/2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New radiation schedule could cut treatment time for throat cancer patients
Disease control Recruiting nowThis phase II trial compares a new, shorter radiation schedule (LT-SABR, given over 1-2 weeks) to standard radiation (over 5-6 weeks) for early-stage laryngeal cancer. The goal is to see if the shorter schedule causes fewer severe side effects in the first 3 months. About 67 adul…
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
AI learns to see inside your throat: new tool could catch disease early
Diagnosis Recruiting nowThis study is developing an artificial intelligence system that can recognize different parts of the throat and nasal passages and detect abnormal growths or lesions. Researchers will train the AI using thousands of endoscopy images and then test its accuracy against doctors with…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New throat test may spot sleep apnea faster
Diagnosis Recruiting nowThis study is testing a new device that measures how sensitive the throat is to help diagnose obstructive sleep apnea (OSA). Researchers will compare the results of this test with standard sleep studies in 117 adults. The goal is to see if this simpler, quicker test can accuratel…
Sponsor: Fundación Neumologica Colombiana • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
A simple arm injection may quiet a mysterious chronic cough
Symptom relief Recruiting nowThis trial investigates whether a single steroid injection into the arm muscle can reduce symptoms of unexplained chronic cough. About 40 adults with chronic cough that has no clear cause will receive either the steroid or a placebo injection. Researchers will track changes in co…
Early phase 1 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Music before surgery: a simple tune to calm nerves?
Symptom relief Recruiting nowThis study tests whether a 20-minute session of passive music therapy, delivered through an app just before entering the operating room, can lower anxiety and pain in adults undergoing ear, nose, or throat surgery. Five hundred participants will be randomly assigned to receive mu…
Sponsor: Clinique Saint-Vincent • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Throat numb shot may soothe vocal cord surgery recovery
Symptom relief Recruiting nowThis study tests whether a numbing injection (nerve block) given during vocal cord surgery can reduce pain, coughing, and improve voice recovery afterward. About 28 adults with benign vocal cord growths will receive either the numbing medicine or a saltwater placebo. Researchers …
Phase 2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Scientists launch massive tissue collection to unlock secrets of head and neck diseases
Knowledge-focused Recruiting nowThis study aims to create a large collection of tissue samples from people with head and neck disorders, such as hearing loss, mouth diseases, and throat cancers. Researchers will use leftover surgical tissue and additional samples like blood, saliva, and cheek swabs to study the…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer
Knowledge-focused Recruiting nowThis early-phase trial tests a fluorescent dye attached to the cancer drug panitumumab to help surgeons see head and neck cancer during surgery. 18 adults with head and neck squamous cell carcinoma will receive the dye before surgery, and a special camera will highlight cancer ti…
Phase 1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New scanner could help surgeons remove all cancer in one go
Knowledge-focused Recruiting nowThis study tests a high-resolution PET-CT scanner that images removed tumors right in the operating room. About 50 adults with solid cancers will get a standard PET tracer before surgery, then the removed tissue is scanned to see if all cancer was taken out. The goal is to see if…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can measuring tongue pressure during surgery prevent pain?
Knowledge-focused Recruiting nowThis study looks at the forces applied to the tongue and throat during laryngeal surgery. Researchers will measure these forces in 100 adults and see if they relate to pain, numbness, or tongue movement after surgery. In the second half of the study, surgeons will see real-time f…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Scientists launch massive biobank to unlock secrets of hearing, smell, and voice disorders
Knowledge-focused Recruiting nowThis study collects leftover tissue samples and additional blood, saliva, and cheek swabs from up to 1,000 people with hearing, balance, smell, taste, voice, or speech disorders. The samples are stored in a biobank for researchers to study the biology of these conditions. No new …
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC